The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes

Diabetes - United States
doi 10.2337/db11-1423
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

C-Peptide Reverses Nociceptive Neuropathy in Type 1 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2006English

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2008English

C-Peptide Persistence in Type 1 Diabetes: ‘Not Drowning, but Waving’?

BMC Medicine
Medicine
2019English

Inverse Relationship Between Glomerular Hyperfiltration and C-Peptide Level in Type 1 Diabetes

Journal of Diabetes Mellitus
2014English

Amelioration of Sensory Nerve Dysfunction by C-Peptide in Patients With Type 1 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2003English

Pregnancy-Induced Rise in Serum C-Peptide Concentrations in Women With Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2009English

Elevations in the Fasting Serum Proinsulin–to–C-Peptide Ratio Precede the Onset of Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2016English

Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2017English

C-Peptide Measurement in the Differentiation of Type 1 (Insulin-Dependent) and Type 2 (Non-Insulin-Dependent) Diabetes Mellitus

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy